Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 2/20 | 0.39 |
| ▸ | F3 | P13726 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 3/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.35 |
| ▸ | PPARG | P37231 | 3/20 | 0.35 |
| ▸ | PPARD | Q03181 | 3/20 | 0.35 |
| ▸ | PPARA | Q07869 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | FABP4 | P15090 | 2/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27585811 | 0.94 | EP300 (0.44) | F7F3EP300TERTPTPN1 | |
| SCHEMBL13424192 | 0.92 | EP300 (0.47) | F7F3EP300TERTPTPN1 | |
| SCHEMBL10047297 | 0.86 | — | — | |
| SCHEMBL11800932 | 0.82 | ALDH1A1 (0.56) | F7F3TSHRPPARGPPARD | |
| SCHEMBL29968566 | 0.80 | F7 (0.35) | F7F3TSHREP300TERT | |
| Acrylic Acid SCHEMBL1259561 | 0.79 | LMNA (0.40) | TSHRHSD17B10LMNAALOX15 | |
| SCHEMBL10047296 | 0.77 | — | — | |
| SCHEMBL28170113 | 0.76 | FASN (0.44) | F7F3TERTPTPN1PPARG | |
| SCHEMBL7769064 | 0.75 | TSHR (0.45) | F7F3TSHRLMNAFAAH | |
| SCHEMBL3165885 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2268740-B1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP ASSETS BV (NL) | 2018-10-03 | — | — | EP | claimed |
| US-9382446-B2 | Aqueous emulsion coating composition comprising an autoxidisable fatty acid modified polyester | DSM IP ASSETS B.V. (NL) | 2016-07-05 | — | — | US | claimed |
| US-20130236694-A1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP ASSETS B.V. (NL) | 2013-09-12 | — | — | US | claimed |
| US-20110064933-A1 | alkyd resin comprising a polyester modified with unsaturated fatty acid such as 2,4-hexadienoic acid; paints for example; smoothness, gloss, reduced telegraphing i.e. good at hiding surface irregularities of substrates such as of wood, quick drying, low VOC | DSM IP ASSETS B.V. (NL) | 2011-03-17 | — | — | US | claimed |
| EP-2268740-A1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP Assets B.V. (NL) | 2011-01-05 | — | — | EP | claimed |
| WO-2009121885-A1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP ASSETS BV (NL) | 2009-10-08 | — | — | WO | claimed |
| US-20240315931-A1 | BASE PASTE AND DENTAL ALGINATE IMPRESSION MATERIAL | GC CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| EP-4410263-A1 | MAIN-MATERIAL PASTE AND DENTAL ALGINATE IMPRESSION MATERIAL | GC Corporation (JP) | 2024-08-07 | — | — | EP | disclosed |
| CN-107722148-B | Solid polyaluminoxane composition, catalyst for olefin polymerization, and method for producing olefin polymer | 三井化学株式会社 | 2021-06-08 | — | — | CN | disclosed |
| EP-2268740-B1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP ASSETS BV (NL) | 2018-10-03 | — | — | EP | disclosed |
| US-20160289494-A1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP ASSETS BV (NL) | 2016-10-06 | — | — | US | disclosed |
| US-9382446-B2 | Aqueous emulsion coating composition comprising an autoxidisable fatty acid modified polyester | DSM IP ASSETS B.V. (NL) | 2016-07-05 | — | — | US | disclosed |
| US-8815935-B2 | Inhibitors of protein prenyltransferases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-08-26 | — | — | US | disclosed |
| US-20130236694-A1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP ASSETS B.V. (NL) | 2013-09-12 | — | — | US | disclosed |
| US-20130102639-A1 | INHIBITORS OF PROTEIN PRENYLTRANSFERASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-04-25 | — | — | US | disclosed |
| US-20110178138-A1 | INHIBITORS OF PROTEIN PRENYLTRANSFERASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-07-21 | — | — | US | disclosed |
| US-20110064933-A1 | alkyd resin comprising a polyester modified with unsaturated fatty acid such as 2,4-hexadienoic acid; paints for example; smoothness, gloss, reduced telegraphing i.e. good at hiding surface irregularities of substrates such as of wood, quick drying, low VOC | DSM IP ASSETS B.V. (NL) | 2011-03-17 | — | — | US | disclosed |
| EP-2268740-A1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP Assets B.V. (NL) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009121885-A1 | AQUEOUS EMULSION COATING COMPOSITION COMPRISING AN AUTOXIDISABLE FATTY ACID MODIFIED POLYESTER | DSM IP ASSETS BV (NL) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102639-A1 | INHIBITORS OF PROTEIN PRENYLTRANSFERASES | RABGGTA, FNTA, RABGGTB | F7 4424/4885F3 3145/4885TSHR 3604/4885 |
| US-20110178138-A1 | INHIBITORS OF PROTEIN PRENYLTRANSFERASES | RABGGTA, FNTA, RABGGTB | F7 4424/4885F3 3145/4885TSHR 3604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.